Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
734 studies found for:    osteoporosis AND (woman OR women OR female)
Show Display Options
RSS Create an RSS feed from your search for:
osteoporosis AND (woman OR women OR female)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Evaluation of an Osteoporosis Prevention Strategy in Women With Osteoporotic Fracture of the Upper Limb
Condition: Osteoporosis With Current Fragility Fracture
Intervention: Behavioral: Osteoporosis prevention program
2 Recruiting Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France
Condition: Post Menopausal Osteoporosis
Intervention: Drug: AMG 162 - Prolia
3 Completed A Study of the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: salmon calcitonin 100 IU/day subcutaneous
4 Completed Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: teriparatide 20 micrograms/day subcutaneous;   Drug: salmon calcitonin 100 IU/day subcutaneous
5 Completed Post-menopausal Women Osteoporosis(Phase III)
Condition: Postmenopausal Women Osteoporosis
Interventions: Drug: risedronate combine;   Drug: Risedronate;   Drug: Placebo(for Risedronate);   Drug: Placebo(for risedronate combine)
6 Completed Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Osteoporosis, Post-Menopausal
Intervention: Drug: teriparatide
7 Active, not recruiting Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Romosozumab;   Drug: Alendronate
8 Completed TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
Condition: Osteoporosis
Interventions: Drug: placebo;   Drug: ALX1-11
9 Unknown  Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
Condition: Osteoporosis
Intervention: Other: Questionnaires about compliance and persistence with bisphosphonates treatment
10 Active, not recruiting Oklahoma Native American Women's Osteoporosis Screening Study
Condition: Osteoporosis
Intervention:
11 Completed STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)
Condition: Postmenopausal Women With Primary Osteoporosis
Intervention: Drug: Parathyroid hormone (PTH)
12 Completed
Has Results
Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
Condition: Osteoporosis
Interventions: Drug: Full Length Parathyroid Hormone, PTH(1-84);   Drug: Strontium Ranelate
13 Completed The Effect of a Short Educational Program on Young Women's Knowledge and Beliefs About Osteoporosis
Condition: Osteoporosis
Intervention: Behavioral: Education
14 Recruiting Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women
Condition: Adult Idiopathic Generalized Osteoporosis
Interventions: Drug: Teriparatide;   Drug: Saline Placebo
15 Recruiting Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
Condition: Osteoporosis
Intervention: Drug: Teriparatide
16 Completed Optimal Management of Women With Wrist Fractures
Conditions: Osteoporosis;   Osteopenia
Intervention: Procedure: Educational Material and Reminder
17 Completed
Has Results
Foot Orthoses and Elderly Women With Osteoporosis
Condition: Osteoporosis
Intervention: Device: Foot orthosis (Orthotics Unit of the Clinical Hospital of UNICAMP)
18 Completed Safety and Efficacy of Whole-body Vibration as add-on Treatment of Osteoporosis in Post-menopausal Women
Condition: Osteoporosis in Post-menopausal Women
Intervention: Device: Whole body vibration
19 Active, not recruiting Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women
Conditions: Menopause;   Fracture;   Osteoporosis
Intervention: Drug: Teriparatide (PTH 1-34)
20 Completed Phase III Clinical Trial of DP-R206 and Bonvia In Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Test group;   Drug: Reference group

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.